Genetic analysis of heme oxygenase-1 (HO-1) in German Parkinson's disease patients

被引：19

作者：

Funke, Claudia ^{[1
]}

Tomiuk, Juergen ^{[1
]}

Riess, Olaf ^{[1
]}

Berg, Daniela ^{[2
]}

Soehn, Anne S. ^{[1
]}

机构：

[1] Univ Tubingen, Dept Med Genet, Inst Human Genet, D-72076 Tubingen, Germany

[2] Univ Tubingen, Hertie Inst Clin Brain Res, D-72076 Tubingen, Germany

来源：

JOURNAL OF NEURAL TRANSMISSION | 2009年 / 116卷 / 07期

关键词：

Parkinson's disease; Heme oxygenase-1; SNaPshot; Single-nucleotide polymorphism (SNP); Case-control study; Fragment length polymorphism; OXIDATIVE STRESS; MICROSATELLITE POLYMORPHISM; TRANSCRANIAL ULTRASOUND; PROMOTER POLYMORPHISM; SUBSTANTIA-NIGRA; IRON-METABOLISM; BRAIN; SUSCEPTIBILITY; ASSOCIATION; BILIRUBIN;

D O I：

10.1007/s00702-009-0237-6

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Parkinson's disease (PD) is characterized by the loss of dopaminergic neurons and the presence of intracytoplasmic inclusions (Lewy bodies). Iron, which is elevated in the substantia nigra (SN) of PD patients, seems to be of pivotal importance, because of its capacity to enhance the amplification of reactive-oxygen species. Therefore, it is tempting that the iron-releasing key enzyme in heme catabolism, heme oxygenase-1 (HO-1), may represent a candidate for a genetic susceptibility to PD. In the current study, we examined a (GT)n fragment length polymorphism in the promoter region, as well as three coding SNPs in the HO-1 gene in order to assess if certain genotypes are associated with PD. Furthermore, peripheral blood expression levels of HO-1 in PD patients and healthy probands were compared. However, our analyses did not reveal a significant association of these genetic markers in the HO-1 gene with an increased susceptibility to PD.

引用

页码：853 / 859

页数：7

共 35 条

[1] Neural roles for heme oxygenase:: Contrasts to nitric oxide synthase [J].

Barañano, DE ;

Snyder, SH .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (20) :10996-11002

[2] Disturbance of iron metabolism in Parkinson's disease ultrasonography as a biomarker [J].

Berg, D ;

Hochstrasser, H ;

Schweitzer, KJ ;

Riess, O .

NEUROTOXICITY RESEARCH, 2006, 9 (01) :1-13

[3] Echogenicity of the substantia nigra -: Association with increased iron content and marker for susceptibility to nigrostriatal injury [J].

Berg, D ;

Roggendorf, W ;

Schröder, U ;

Klein, R ;

Tatschner, T ;

Benz, P ;

Tucha, O ;

Preier, M ;

Lange, KW ;

Reiners, K ;

Gerlach, M ;

Becker, G .

ARCHIVES OF NEUROLOGY, 2002, 59 (06) :999-1005

[4] Echogenicity of substantia nigra determined by transcranial ultrasound correlates with severity of parkinsonian symptoms induced by neuroleptic therapy [J].

Berg, D ;

Jabs, B ;

Merschdorf, U ;

Beckmann, H ;

Becker, G .

BIOLOGICAL PSYCHIATRY, 2001, 50 (06) :463-467

[5] Brain iron pathways and their relevance to Parkinson's disease [J].

Berg, D ;

Gerlach, M ;

Youdim, MBH ;

Double, KL ;

Zecca, L ;

Riederer, P ;

Becker, G .

JOURNAL OF NEUROCHEMISTRY, 2001, 79 (02) :225-236

[6] Vulnerability of the nigrostriatal system as detected by transcranial ultrasound [J].

Berg, D ;

Becker, G ;

Zeiler, B ;

Tucha, O ;

Hofmann, E ;

Preier, M ;

Benz, P ;

Jost, W ;

Reiners, K ;

Lange, KW .

NEUROLOGY, 1999, 53 (05) :1026-1031

[7]

BERG D, 2006, J NEURAL TRANSM-SUPP, V24, P9

[8]

CARY NC, 2003, SAS USERS GUIDE STAT

[9]

Cheng N, 2002, MOL CANCER RES, V1, P2

[10]

Dennery PA, 2000, CURR TOP CELL REGUL, V36, P181

← 1 2 3 4 →